GH 44.05 (-5.98%)
US40131M1099Medical Diagnostics & ResearchDiagnostics & Research

Guardant Health (GH) Competitor Comparison

We are evaluating the key criteria listed to compare Guardant Health (GH) against its competitors in the Diagnostics & Research industry.

Performance 5 years - GH ranking 30 / 58

These are the competitors of Guardant Health in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
753.6
2. Natera NTRA
327.43
3. RadNet RDNT
294.73
4. Medpace Holdings MEDP
275.42
5. Meridian Bioscience VIVO
118.46
6. Waters WAT
90.86
7. Laboratory Corp of America Holdings LH
79.91
8. IDEXX Laboratories IDXX
74.08
9. Quest Diagnostics DGX
64.14
10. DarioHealth DRIO
61.4
11. Mettler-Toledo MTD
57.17
12. PerkinElmer PKI
48.44
13. Agilent Technologies A
44.67
14. Danaher DHR
36.7
15. Fulgent Genetics FLGT
27.98
16. Thermo Fisher Scientific TMO
27.21
17. Twist Bioscience TWST
25.69
18. Anixa Biosciences ANIX
23.56
19. Ortho Clinical Diagnostics Holdings OCDX
13.74
20. Heska HSKA
12.14
21. IQVIA Holdings IQV
12.01
22. Co-Diagnostics CODX
6.45
23. Qiagen QGEN
2.54
24. Icon ICLR
-1.67
25. DexCom DXCM
-10.8
26. Charles River Laboratories CRL
-14.97
27. Syneos Health SYNH
-16.98
28. Olink Holding OLK
-26.82
29. Exact Sciences EXAS
-32.06
30. Guardant Health GH
-41.16
31. CareDx CDNA
-44.09
32. Myriad Genetics MYGN
-48.71
33. Precipio PRPO
-49.52
34. Bioventus BVS
-51.39
35. Sotera Health SHC
-52.15
36. Personalis PSNL
-57.55
37. Inotiv NOTV
-57.8
38. Psychemedics PMD
-60.03
39. Exagen XGN
-61.16
40. Pacific Biosciences of California PACB
-65.23
41. Enzo Biochem ENZ
-65.26
42. NeoGenomics NEO
-70.33
43. Illumina ILMN
-74.11
44. National Research NRC
-75.46
45. Sera Prognostics SERA
-80.61
46. Neogen NEOG
-80.96
47. Trinity Biotech TRIB
-81.02
48. MaxCyte MXCT
-83.4
49. MDxHealth MDXH
-85.84
50. Global Cord Blood CO
-86.47
51. Interpace Biosciences IDXG
-86.51
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.55

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.